dc.contributor.author |
Heim, Christopher |
|
dc.contributor.author |
Hartmann, Marcus |
|
dc.date.accessioned |
2023-10-24T09:43:13Z |
|
dc.date.available |
2023-10-24T09:43:13Z |
|
dc.date.issued |
2023 |
|
dc.identifier.issn |
0223-5234 |
|
dc.identifier.uri |
http://hdl.handle.net/10900/146826 |
|
dc.language.iso |
en |
de_DE |
dc.publisher |
Elsevier France - Editions Scientifiques Medicales Elsevier |
de_DE |
dc.relation.uri |
http://dx.doi.org/10.1016/j.ejmech.2022.114990 |
de_DE |
dc.subject.ddc |
540 |
de_DE |
dc.title |
Synthesis of novel glutarimide ligands for the E3 ligase substrate receptor Cereblon (CRBN): Investigation of their binding mode and antiproliferative effects against myeloma cell lines |
de_DE |
dc.type |
Article |
de_DE |
utue.quellen.id |
20230619000000_01857 |
|
utue.personen.roh |
Krasavin, Mikhail |
|
utue.personen.roh |
Adamchik, Maria |
|
utue.personen.roh |
Bubyrev, Andrey |
|
utue.personen.roh |
Heim, Christopher |
|
utue.personen.roh |
Maiwald, Samuel |
|
utue.personen.roh |
Zhukovsky, Daniil |
|
utue.personen.roh |
Zhmurov, Petr |
|
utue.personen.roh |
Bunev, Alexander |
|
utue.personen.roh |
Hartmann, Marcus D. |
|
dcterms.isPartOf.ZSTitelID |
European Journal of Medicinal Chemistry |
de_DE |
dcterms.isPartOf.ZS-Issue |
Article 114990 |
de_DE |
dcterms.isPartOf.ZS-Volume |
246 |
de_DE |
utue.fakultaet |
04 Medizinische Fakultät |
de_DE |
utue.fakultaet |
07 Mathematisch-Naturwissenschaftliche Fakultät |
de_DE |